JBM (Healthcare) (HKG:2161) unit Arrow King completed the acquisition of a 90% equity stake in Tin Hee Tong Medicine Factory for HK$171 million, a Thursday filing with the Hong Kong bourse said.
The parties had entered into the purchase agreement in February.
Tin Hee Tong Medicine Factory engages mainly in the manufacture, marketing, and sales of proprietary Chinese medicine Tin Hee Tong Tin Hee Pills.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.